Literature DB >> 12062500

Non-linear mixed effects models for the evaluation of dissolution profiles.

E Adams1, D Coomans, J Smeyers-Verbeke, D L Massart.   

Abstract

The use of non-linear mixed effects models to describe dissolution data has been evaluated. A theoretical part is included to introduce this approach to scientists who are not familiar with this type of statistics. The standard settings of the statistical software package (S-plus) are used as much as possible. Several mathematical functions like the Weibull, logistic, first-order and Gompertz are employed as basis for the non-linear mixed effects models. Examples are given using dissolution data of immediate and extended release tablets. The results are compared with those obtained using linear mixed effects models.

Mesh:

Substances:

Year:  2002        PMID: 12062500     DOI: 10.1016/s0378-5173(02)00127-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations.

Authors:  Elena Soto; Sebastian Haertter; Michael Koenen-Bergmann; Alexander Staab; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2009-12-29       Impact factor: 4.200

2.  Dissolution comparisons using a Multivariate Statistical Distance (MSD) test and a comparison of various approaches for calculating the measurements of dissolution profile comparison.

Authors:  J-M Cardot; B Roudier; H Schütz
Journal:  AAPS J       Date:  2017-03-28       Impact factor: 4.009

3.  Patient-friendly extemporaneous formulation of bisoprolol: application to stability and bioavailability studies.

Authors:  Soha M El-Masry; Sally A Helmy; Soha A M Helmy; Eman A Mazyed
Journal:  Drug Deliv Transl Res       Date:  2022-10-03       Impact factor: 5.671

4.  Hydroxyapatite coating by sol-gel on Ti-6Al-4V alloy as drug carrier.

Authors:  Eduardo Peón Avés; Gaston Fuentes Estévez; Marcia Soares Sader; Juan C Galván Sierra; Julio C Llópiz Yurell; Ivan N Bastos; Gloria D Almeida Soares
Journal:  J Mater Sci Mater Med       Date:  2008-12-18       Impact factor: 3.896

5.  Cyclodextrin-crosslinked poly(acrylic acid): adhesion and controlled release of diflunisal and fluconazole from solid dosage forms.

Authors:  Marguerite J Kutyła; Michael W Boehm; Jason R Stokes; P Nicholas Shaw; Nigel M Davies; Ross P McGeary; Jonathan Tuke; Benjamin P Ross
Journal:  AAPS PharmSciTech       Date:  2013-01-11       Impact factor: 3.246

6.  Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.

Authors:  Lukas Uebbing; Lukas Klumpp; Gregory K Webster; Raimar Löbenberg
Journal:  Drug Des Devel Ther       Date:  2017-04-11       Impact factor: 4.162

7.  In vitro release studies of furosemide reference tablets: influence of agitation rate, USP apparatus, and dissolution media.

Authors:  Raúl Medina-López; Sergio Guillén-Moedano; Marcela Hurtado
Journal:  ADMET DMPK       Date:  2020-06-29

8.  Effect of the Addition of Alginate and/or Tetracycline on Brushite Cement Properties.

Authors:  Claudia Morilla; Elianis Perdomo; Ana Karla Hernández; Ramcy Regalado; Amisel Almirall; Gastón Fuentes; Yaima Campos Mora; Timo Schomann; Alan Chan; Luis J Cruz
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.